Spatial Tumor Immune Microenvironment as a Prognostic and Predictive Biomarker in Anti–EGFR-Based Maintenance for <i>RAS</i> wt Metastatic CRC—The PanaMa (AIO KRK0212) Trial
- DOI
- 10.1158/1078-0432.ccr-25-0879
- Published
- 2025-07-30
- Container
- Clinical Cancer Research
- Publisher
- American Association for Cancer Research (AACR)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1158/1078-0432.ccr-25-0879,
title = {Spatial Tumor Immune Microenvironment as a Prognostic and Predictive Biomarker in Anti–EGFR-Based Maintenance for
<i>RAS</i>
wt Metastatic CRC—The PanaMa (AIO KRK0212) Trial},
author = {Alexej Ballhausen and Susanna Swoboda and David Horst and Stefan Fruehauf and Ullrich Graeven and Lothar Müller and Tanja Trarbach and Ludwig Fischer von Weikersthal and Eray Goekkurt and Volker Heinemann and Stefan Kasper and Annika Kurreck and Annabel Helga Sophie Alig and Anke C. Reinacher-Schick and Lars Bullinger and Arndt Stahler and Sebastian Stintzing and Armin Jarosch and Dominik P. Modest},
year = {2025},
journal = {Clinical Cancer Research},
doi = {10.1158/1078-0432.ccr-25-0879},
url = {https://doi.org/10.1158/1078-0432.ccr-25-0879}
}RIS
TY - JOUR
TI - Spatial Tumor Immune Microenvironment as a Prognostic and Predictive Biomarker in Anti–EGFR-Based Maintenance for
<i>RAS</i>
wt Metastatic CRC—The PanaMa (AIO KRK0212) Trial
AU - Alexej Ballhausen
AU - Susanna Swoboda
AU - David Horst
AU - Stefan Fruehauf
AU - Ullrich Graeven
AU - Lothar Müller
AU - Tanja Trarbach
AU - Ludwig Fischer von Weikersthal
AU - Eray Goekkurt
AU - Volker Heinemann
AU - Stefan Kasper
AU - Annika Kurreck
AU - Annabel Helga Sophie Alig
AU - Anke C. Reinacher-Schick
AU - Lars Bullinger
AU - Arndt Stahler
AU - Sebastian Stintzing
AU - Armin Jarosch
AU - Dominik P. Modest
PY - 2025
JO - Clinical Cancer Research
DO - 10.1158/1078-0432.ccr-25-0879
UR - https://doi.org/10.1158/1078-0432.ccr-25-0879
ER - APA
Ballhausen, A., Swoboda, S., Horst, D., Fruehauf, S., Graeven, U., Müller, L., Trarbach, T., Weikersthal, L. F. V., Goekkurt, E., Heinemann, V., Kasper, S., Kurreck, A., Alig, A. H. S., Reinacher-Schick, A. C., Bullinger, L., Stahler, A., Stintzing, S., Jarosch, A., & Modest, D. P. (2025). Spatial Tumor Immune Microenvironment as a Prognostic and Predictive Biomarker in Anti–EGFR-Based Maintenance for <i>RAS</i> wt Metastatic CRC—The PanaMa (AIO KRK0212) Trial. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-25-0879
Source records
- crossref · retrieved 2026-09-26T20:25:55.400Z